tiprankstipranks
Silo Pharma exercises option to license SPC-14 from Columbia University
PremiumThe FlySilo Pharma exercises option to license SPC-14 from Columbia University
1M ago
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
PremiumPress Releases
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
2M ago
Silo Pharma exercises options for exclusive license agreement
PremiumThe Fly
Silo Pharma exercises options for exclusive license agreement
2M ago
Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
PremiumPress ReleasesSilo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
3M ago
Silo Pharma says SP-26 ketamine implant demonstrates ‘successful’ drug delivery
PremiumThe Fly
Silo Pharma says SP-26 ketamine implant demonstrates ‘successful’ drug delivery
3M ago
Silo Pharma Prioritizes Mental Health in 2024 Pipeline
PremiumCompany Announcements
Silo Pharma Prioritizes Mental Health in 2024 Pipeline
4M ago
Silo Pharma files $25M mixed securities shelf
PremiumThe FlySilo Pharma files $25M mixed securities shelf
4M ago
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
PremiumPress Releases
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
5M ago
Silo Pharma completes first phase of dose-ranging study of SPC-15
PremiumThe Fly
Silo Pharma completes first phase of dose-ranging study of SPC-15
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100